Sanofi/SAN

€89.07

-0.11%
-
1D1W1MYTD1YMAX

About Sanofi

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Ticker

SAN

Sector

Healthcare

Trading on

PAR

Industry

Biotechnology & Drugs

CEO

Paul Hudson

Employees

87,994

Headquarters

Paris, France
Website
www.sanofi.com

Sanofi Metrics

BasicAdvanced
€113B
Market cap
24.70
P/E ratio
€3.61
EPS
0.50
Beta
€3.76
Dividend rate
4.22%
Dividend yield
€113B
0.49637
€104.32
€80.60
1.4M
€3.76
103.68%
45.17%
24.7
2.418
3.9%
4.22%
4.22%
1.08%
-45.69%
7.52%
-23.91%
5.52%

What the Analysts think about Sanofi

Analyst Ratings

Majority rating from 26 analysts.
Buy

Price Targets

Average projection from 24 analysts.
19.8% upside
High €125.00
Low €80.00
€89.07
Current price
€106.71
Average price target

Sanofi Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.19% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
€11B
-55.35%
Net income
€1.1B
-42.49%
Profit margin
10.19%
28.82%

Sanofi Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.34%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
€1.74
€2.55
€1.66
€1.78
-
Expected
€1.67
€2.58
€1.68
€1.72
€1.58
Surprise
4.31%
-1.34%
-1.44%
3.34%
-
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Euronext. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Sanofi stock?

Sanofi (SAN) has a market cap of €113B as of May 20, 2024.

What is the P/E ratio for Sanofi stock?

The price to earnings (P/E) ratio for Sanofi (SAN) stock is 24.7 as of May 20, 2024.

Does Sanofi stock pay dividends?

Yes, the Sanofi (SAN) stock pays dividends to shareholders. As of May 20, 2024, the dividend rate is €3.76 and the yield is 4.22%. Sanofi has a payout ratio of 103.68% on a trailing twelve-month basis.

When is the next Sanofi dividend payment date?

The next Sanofi (SAN) dividend payment date is unconfirmed.

What is the beta indicator for Sanofi?

Sanofi (SAN) has a beta rating of 0.5. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Sanofi stock price target?

The target price for Sanofi (SAN) stock is €106.71, which is 19.8% above the current price of €89.07. This is an average based on projections from 24 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Sanofi stock

Buy or sell Sanofi stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing